Zopiclone. An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia

Drugs

Volumn 55, Issue 2, 1998, Pages 277-302

  Noble, Stuart ^a   Langtry, Heather D ^a   Lamb, Harriet M ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; FLURAZEPAM; HYPNOTIC AGENT; ZOPICLONE;

ANTEROGRADE AMNESIA; CLINICAL TRIAL; DRUG DEPENDENCE; DRUG EFFICACY; DRUG TOLERANCE; DRUG WITHDRAWAL; HUMAN; INSOMNIA; META ANALYSIS; NAUSEA; NIGHTMARE; REBOUND; REVIEW; SOMNOLENCE; TASTE DISORDER; XEROSTOMIA;

BENZODIAZEPINES; CLINICAL TRIALS; HUMANS; HYPNOTICS AND SEDATIVES; PIPERAZINES; SLEEP INITIATION AND MAINTENANCE DISORDERS; TASTE;

EID: 0031915604     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199855020-00015     Document Type: Review

References (110)

1. Goa KL, Heel RC. Zopiclone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic. Drugs 1986 Jul; 32: 48-65
2. A receptor function is different from that of benzodiazepines. Naunyn Schmiedebergs Arch Pharmacol 1994 Sep; 350: 294-300
3. A/benzodiazepine receptor. Adv Biochem Psychopharmacol 1992; 47: 407-18
4. Serra M, Concas A, Biggio G. Failure of long-term administration of zopiclone and zolpidem to induce tolerance in mice. Neurosci Res Commun 1996 Nov-Dec; 19: 169-78
5. Kanno O, Watanabe H, Kazamatsuri H. Effects of zopiclone, flunitrazepam, triazolam and levomepromazine on the transient change in sleep-wake schedule: polygraphic study, and the evaluation of sleep and daytime condition. Prog Neuropsych Biol Psychiatry 1992 Mar; 17: 229-39
6. Kummer J, Gündel L, Seyffer B. Effects of zopiclone on sleep-EEG and daytime well-being in the elderly [abstract]. Eur Psychiatry 1994; 9 Suppl. 1: 138
7. Parrino L, Terzano MG. Polysomnographic effects of hypnotic drugs: a review. Psychopharmacology 1996 Jul; 126: 1-16
8. Hayashida N, Nakazawa Y, Sakamoto T, et al. Effects of zopiclone on slow wave sleep and spontaneous K-complexes for normal healthy young adults. Jpn J Psychiatry Neurol 1993 Dec; 47: 893-9
9. Yamadera H, Kato M, Tsukahara Y, et al. Relationship between the effects of a hypnotic drug, zopiclone, on polysomnography and on daytime EEGs. Neuropsychobiology 1997; 35: 152-5
10. Kim Y-D, Zhuang H-Y, Tsutsumi M, et al. Comparison of the effect of zopiclone and brotizolam on sleep EEG by quantitative evaluation in healthy young women. Sleep 1993 Oct; 16: 655-61
11. Mann K, Bauer H, Hiemke C, et al. Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion. Eur Neuropsychopharmacol 1996 Aug; 6: 163-8
12. Parrino L, Boselli M, Spaggiari MC, et al. Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating pattern. Clin Neuropharmacol 1997; 20 (3): 253-63
13. Billiard M, Bessel A, de Lustrac C, et al. Dose-response effects of zopiclone on night sleep and on nighttime and daytime functioning. Sleep 1987; 10 Suppl. 1: 27-34
14. Nicholson AN, Stone BM. Efficacy of zopiclone in middle age. Sleep 1987; 10 Suppl. 1: 35-9
15. Kajimura N, Kato M, Okuma T, et al. A quantitative sleep-EEG study on the effects of benzodiazepine and zopiclone in schizophrenic patients. Schizophr Res 1995 May; 15: 303-12
16. Mouret J, Ruel D, Maillard F, et al. Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone. Int Clin Psychopharmacol 1990 Apr; 5 Suppl. 2: 47-55
17. Fleming JA, Bourgouin J, Hamilton P. A sleep laboratory evaluation of the long-lerm efficacy of zopiclone. Can J Psychiatry 1988 Mar; 33: 103-7
18. Agnoli A, Manna V, Martucci N. Double-blind study on the hypnotic and antianxiety effects of zopiclone compared with nitrazepam in the treatment of insomnia. Int J Clin Pharmacol Res 1989; 9: 277-81
19. Klimm HD, Dreyfus JF, Delmotte M. Zopiclone versus nitrazepam: a double-blind comparative study of efficacy and tolerance in elderly patients with chronic insomnia. Sleep 1987; 10 Suppl. 1: 73-8
20. Ponciano E., Freitas F, Camara J, et al. A comparison of the efficacy, tolerance and residual effects, of zopiclone, flurazepam and placebo in insomniac outpatients. Int Clin Psychopharmacol 1990 Apr; 5 Suppl. 2: 69-77
21. Tamminen T, Hansen PP. Chronic administration of zopiclone and nitrazepam in the treatment of insomnia. Sleep 1987; 10 Suppl. 1: 63-72
22. Ngen CC, Hassan R. A double-blind placebo-controlled trial of zopiclone 7.5 mg and temazepam 20 mg in insomnia. Int Clin Psychopharmacol 1990 Jul; 5: 165-71
23. Moon CAL, Hindmarch I, Holland RL. The effect of zopiclone 7.5 mg on the sleep, mood and performance of shift workers. Int Clin Psychopharmacol 1490 Apr; 5 Suppl. 2: 79-83
24. Warot D, Bensimon G, Danjou P, et al. Comparative effects of zopiclone, triazolam and placebo on memory and psychomotor performance in healthy volunteers. Fundam Clin Pharmacol 1987; 1: 145-52
25. Saano V, Hansen PP, Paronen P. Interactions and comparative effects of zopiclone, diazepam and lorazepam on psychomotor performance and on elimination pharmacokinetics in healthy volunteers. Pharmacol Toxicol 1992 Feb; 70: 135-9
26. Allain H, Patat A, Lieury A, et al. Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics. Eur Psychiatry 1995; 10 Suppl. 3: 129-35
27. Broadhurst A, Cushnaghan RC. Residual effects of zopiclone (Imovane). Sleep 1987: 10 Suppl. 1: 48-53
28. Hergueta T, Molinier P, Olivieri AN, et al. Effects of loprazolam, zolpidem and zopiclone on memory, vigilance and postural control during nocturnal and morning awakenings in healthy subjects [abstract]. Methods Find Exp Clin Pharmacol 1996; 18 Suppl. B: 203
29. Fossen A, Godlibsen OB, Loyning Y, et al. Effects of hypnotics on memory. Pharmacology 1983: 27 Suppl. 2: 116-26
30. Julou L, Blanchard JC, Dreyfus JF. Pharmacological and clinical studies of cyclopyrrolones: zopiclone and suriclone. Pharmacol Biochem Behav 1988; 23: 653-9
31. Fontaine R, Beaudry P, Le Morvan P. zopiclone and triazolam m insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety. Int Clin Psychopharmacol 1990 Jul; 5: 173-83
32. Tada K, Sato Y, Sakai T, et al. Effects of zopiclone, triazolam, and nitrazepam on standing steadiness. Neuropsychobiology 1994 Jan; 29: 17-22
33. Kuri T, Inoue Y, Shimizu O, et al. The effect of zopiclone on blood pressure [abstract]. Jpn J Psychiatry Neurol 1944 Sep; 48: 677
34. Jobert M, Poiseau H, Jähnig P, et al. ECG activity in the sleep of insomniac patients under the influence of lormetazepam and zopiclone. Neuropsychobiology 1995; 31 (4): 204-4
35. Gaillot J, Le Roux Y, Houghton GW, et al. Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency. Sleep 1987: 10 Suppl. 1: 7-21
36. Gaillot J, Heusse D, Hougton GW, et al. Pharmacokinetics and metabolism of zopiclone. Pharmacology 1483; 27 Suppl. 2: 76-91
37. Caille G, Du Souich P, Spenard J, et al. Pharmacokinetic and clinical parameters of zopiclone and trimipramine when administered simultaneously to volunteers. Biopharm Drug Dispos 1984; 5: 117-25
38. Viron B, De Meyer M, Le Liboux A, et al. Steady state pharmacokinetics of zopiclone during multiple oral dosing (7.5 mg nocte) in patients with severe chronic renal failure. Int Clin Psychopharmacol 1990 Apr; 5 Suppl. 2: 95-104
39. Marc-Aurele J, Caille G, Bourgoin J. Comparison of zopiclone pharmacokinetics in patients with impaired renal function and normal subjects. Effect of hemodialysis. Sleep 1987: 10 Suppl. 1: 22-6
40. Matheson I, Sande HA, Gaillot J. The excretion of zopiclone into breast milk. Br J Clin Pharmacol 1990 Aug; 30: 267-71
41. Luurila H, Olkkola KT. Pharmacokinetic-pharmacodynamic modelling of zopiclone effects on human central nervous system. Pharmacol Toxicol 1996 May; 78: 348-53
42. Fernandez C, Maradeix V, Gimenez F, et al. Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers. Drug Metab Dispos 1993 Nov-Dec; 21: 1125-8
43. Foster RT, Caillé G, Ngoc AH, et al. Pharmacokinetics of zopiclone enantiomers in humans following oral dose administration of racemate [abstract]. Pharm Res 1994 Oct; 11 Suppl.: 402
44. O'Toole DP, Carlisle RJT, Howard PJ, et al. The influence of altered gastric emptying rates on orally administered zopiclone pharmacokinetics [abstract]. Br J Clin Pharmacol 1985; 21 (5); 615P
45. Kuitunen T, Mattila MJ, Seppala T, et al. Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests. Br J Clin Pharmacol 1990 Sep; 30: 453-61
46. Villikka K, Kivistö KT, Lumberg TS, et al. Concentrations and effects of zopiclone are greatly reduced by rifampicin. Br J Clin Pharmacol 1997; 43: 471-4
47. Jalava K-M, Olkkola KT, Neuvonen PJ. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zopiclone. Eur J Clin Pharmacol 1996 Nov-Dec; 51: 331-4
48. Aranko K, Luurila H, Backman JT, et al. The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone. Br J Clin Pharmacol 1994 Oct; 38: 363-7
49. Dundee JW, Wilson CM, Robinson FP, et al. The effect of ranitidine on the hypnotic action of single doses of mid-azolam, temazepam and zopiclone [abstract]. Br J Clin Pharmacol 1984 Apr; 19 (4): 553P-4P
50. Misaki K, Kishi H, Koshino Y, et al. The influence on sleep by zopiclone or ethanol alone or in combination: a polysomnographic study [abstract]. Jpn J Psychiatry Neurol 1991 Dec; 45: 915-6
51. Kuitunen T, Mattila MJ, Seppala T. Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol. Int Clin Psychopharmacol 1990 Apr; 5 Suppl. 2: 115-30
52. Fernandez C, Martin C, Gimenez F, et al. Clinical pharmacokinetics of zopiclone. Clin Pharmacokinet 1995 Dec; 29: 431-41
53. Nair NPV, Schwartz G, Dimitri R, et al. A dose-range finding study of zopiclone in insomniac patients. Int Clin Psychopharmacol 1990 Apr; 5 Suppl. 2: 1-10
54. Goldenberg F, Hindmarch I, Joyce CRB, et al. zopiclone, sleep and health-related quality of life. Hum Psychopharm 1994 Jul-Aug; 9: 245-51
55. Leger D, Quera-Salva MA, Philip P. Health-related quality of life in patients with insomnia treated with zopiclone. PharmacoEconomics 1996: 10 Suppl. 1: 39-44
56. Elie R, Lavoie G, Bourgouin J, et al. Zopiclone versus flurazepam in insomnia: prolonged administration and withdrawal. Int Clin Psychopharmacol 1990 Oct; 5: 279-86
57. Singh AN, Bourgouin J. Comparison of zopiclone and flurazepam treatments in insomnia. Hum Psychopharm 1990 Sep; 5: 217-23
58. Anderson AA. Zopiclone and nitrazepam: a multicenter placebo controlled comparative study of efficacy and tolerance in insomniac patients in general practice. Sleep 1987; 10 Suppl. 1: 54-62
59. Hajak G, Clarenbach P, Fischer W, et al. Zopiclone improves sleep quality and daytime well-being in insomniac patients: comparison with triazolam, flunitrazepam and placebo. Int Clin Psychopharmacol 1994; 9: 251-61
60. Van Moffaert M, Wilmotte J, Mesters P, et al. Comparison of zopiclone and flunitrazepam in the treatment of insomnia in depressed patients. Curr Ther Res 1990 Jul; 48: 140-53
61. van der Kleijn E. Effects of zopiclone and temazepam on sleep, behaviour and mood during the day. Eur J Clin Pharmacol 1989; 36: 247-51
62. Autret E, Maillard F, Autret A. Comparison of the clinical hypnotic effects of zopiclone and triazolam. Eur J Clin Pharmacol 1987; 31: 621-3
63. Chaudoir PJ, Bodkin NL, O'Donnell J, et al. A comparative study of zopiclone and triazolam in patients with insomnia. Int Clin Psychopharmacol 1990 Apr; 5 Suppl. 2: 21-7
64. Fleming JA, McClure DJ, Mayes C, et al. A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia. Int Clin Psychopharmacol 1990 Apr; 5 Suppl. 2: 29-37
65. Hayoun G, Bagot C. Comparative efficacy and safety of triazolam and zopiclone in insomniacs seen in general practice. Curr Ther Res 1989 Dec; 46: 1236-44
66. Begg EJ, Robson RA, Frampton CM, et al. A comparison of efficacy and tolerance of the short acting sedatives mid-azolam and zopiclone. N Z Med J 1992 Oct 28; 105: 428-9
67. Pecknold J, Wilson R, Le Morvan P. Long term efficacy and withdrawal of zopiclone: a sleep laboratory study. Int Clin Psychopharmacol 1990 Apr; 5 Suppl. 2: 57-67
68. Brun JP. Zopiclone, a cyclopyrrolone hypnotic: review of properties [in English]. Pharmacol Biochem Behav 1988 Apr; 29: 831-2
69. Dehlin O, Rubin B, Rundgren A. Double-blind comparison of zopiclone and flunitrazepam in elderly insomniacs with special focus on residual effects. Curr Med Res Opin 1995; 13 (6): 317-24
70. Elie R, Frenay M, Le Morvan P, et al. Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs. Int Clin Psychopharmacol 1990 Apr; 5 Suppl. 2: 39-46
71. Shapiro CM, Sherman D, Peck DF. Withdrawal from benzodiazepines by initially switching to zopiclone. Eur Psychiatry 1995; 10 Suppl. 3: 145s-51
72. Krygier C. BZD substitution study with zopiclone 7.5 ing [abstract]. Clin Neuropharmacol 1992; 15 Suppl. 1 (Pt B): 273B
73. van Bodegom WJ, van der Meij N. Sleep and daytime functioning in patients switched to zopiclone from other hypnotics [abstract]. Sleep Res 1991; 20 (Pt A): 401
74. van der Meij N. Sleep and daytime fitness in elderly patients switched to zopiclone from other hypnotics [abstract]. Sleep Res 1991: 20 (Pt A): 402
75. Lemoine P. Withdrawal of benzodiazepine hypnotics with zopiclone [abstract]. J Sleep Res 1994 Jun; 3 Suppl. 1: 146
76. Allain H, Delahaye C, Le Coz F, et al. Postmarketing surveillance of zopiclone in insomnia: analysis of 20,513 cases. Sleep 1991 Oct; 14: 408-13
77. Inman W, Kubota K, Pearce G, et al. PEM Report Number 10. Zopiclone. Pharmacoepidemiol Drug Saf 1993 Jul-Oct; 2: 499-521
78. Monti JM, Monti D. Pharmacological treatment of chronic insomnia. CNS Drugs 1995; 4 (3): 182-94
79. Dingemanse J. Pharmacotherapy of insomnia: practice and prospects. Pharm World Sci 1995; 17 (3): 67-75
80. Hajak G, Rodenbeck A. Clinical management of patients with insomnia: the role of zopiclone. PharmacoEconomics 1996; 10 Suppl. 1: 29-38
81. Dobbins SE. Zimovane - a post marketing surveillance in general practice - interim report [abstract]. J Psychopharmacol 1992; 6: 131
82. Bianchi M, Musch B. Zopiclone discontinuation: review of 25 studies assessing withdrawal and rebound phenomena. Int Clin Psychopharmacol 1990 Apr; 5 Suppl. 2: 139-45
83. Sullivan G, McBride AJ, Clee WB. Zopiclone abuse in South Wales: three case reports. Hum Psychopharm 1995 Jul-Aug; 10: 351-2
84. Thakore J, Dinan TG. Physical dependence following zopiclone usage: a case report. Hum Psychopharm 1992 Mar-Apr; 7: 143-5
85. Sikdar S, Ruben SM. Zopiclone abuse among polydrug users [letter]. Addiction 1996 Feb; 91: 285-6
86. Dreyfus JF. Zopiclone: clinical efficacy and tolerance. Rhöne-Poulenc Rorer. Symposium on zopiclone: 1981 Jul 17; Tokyo, 103-17. (Data on file)
87. Lemoine P, Allain H, Janus C, et al. Gradual withdrawal of zopiclone (7.5 mg) and zolpidem (10 mg) in insomniacs treated for at least 3 months. Eur Psychiatry 1995: 10 Suppl. 3: 161-5
88. Mannaert E, Tytgat J, Daenens P. Detection and quantification of the hypnotic zopiclone, connected with an uncommon case of drowning. Forensic Sci Int 1996; 83 (1): 67-72
89. Boniface PJ, Russell SGG. Two cases of fatal zopiclone overdose. J Anal Toxicol 1996 Mar-Apr; 20: 131-3
90. Pounder DJ, Davies JI. Zopiclone poisoning: tissue distribution and potential for postmortem diffusion. Forensic Sci Int 1994 May 13; 65: 177-83
91. Meatherall RC. Zopiclone fatality in a hospitalized patient. J Forensic Sci 1996; 42 (2): 340-3
92. Rhône-Poulenc Rorer. Zopiclone monograph. Rhône-Poulenc Rorer (Antony ), 1994. (Data on file)
93. Rhône-Poulenc Rorer. Zimovane* prescribing information
94. Pons G, Rey E, Matheson I. Excretion of psychoactive drugs into breast milk. Pharmacokinetic principles and recommendations. Clin Pharmacokinet 1994 Oct; 27: 270-89
95. Maczaj M. Pharmacological treatment of insomnia. Drugs 1993; 45 (1): 44-55
96. Woodward MC. The management of insomnia in older people. Aust J Hosp Pharmacy 1996; 26 (4): 462-465
97. Chilcott LA, Shapiro CM. The socioeconomic impact of insomnia: an overview. PharmacoEconomics 1996; 10 Suppl. 1: 1-14
98. Walsh JK, Mahowald MW. Avoiding the blanket approach to insomnia. Targeted therapy for specific causes. Postgrad Med 1991 Jul; 90: 211-24
99. Kupfer DJ, Reynolds IIICF. Management of insomnia. N Engl J Med 1997 Jan 30; 336: 341-6
100. Ashton CH. Management of insomnia. Prescr J 1997; 37 (1): 1-11
101. Lader M. Psychiatric disorders. In: Speight TM, Holford NHG, editors. Avery's drug treatment. 4th ed. Auckland; Adis International Limited, 1997: 1395-453
102. National Heart Lung and Blood Institute. Facts about insomnia. National Heart Lung and Blood Institute. Available from: URL: gopher://fido.nhlbi.nih.gov/00/nhlbi/health/sleep/gp/insomnia.txt [Accessed 1997 Sep 5]. Also available as Adobe Acrobat (PDH) file from: URL: http//www.nhlbi.nih.gov/nhlbi/sleep/gp/insomnia.htm
103. Bassa R, Law J, Goldberg LA. Hypnotics usage among elderly patients in homes and hospital wards in Salford. Pharm J 1994; 252 (6783): 474-6
104. Ohayon MM, Caulet M. Psychotropic medication and insomnia complaints in two epidemiological studies. Can J Psychiatry 1996; 41 (7): 457-64
105. Rayón P, Serrano-Castro M, del Barrio H, et al. Hypnotic drug use in Spain: a cross-sectional study based on a network of community pharmacies. Annals of Pharmacotherapy 1996; 30 (10): 1092-100
106. Lahmeyer H. Hypnotics: a powerful tool for a serious problem. Pharmacol Ther 1995 July; 20: 438-55
107. Ashton H. Guidelines for the rational use of benzodiazepines: when and what to use. Drugs 1994; 48 (1): 25-40
108. Ghaeli P, Dufresne RL, Stoukides CA. Triazolam treatment controversy. Ann Pharmacother 1994; 28 (9): 1038-40
109. Hoehns JD, Perry PJ. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia. Clin Pharm 1993 Nov; 12: 814-28
110. Langtry HD, Benfield P. Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1990 Aug; 40: 291-313